Menu

Blog

Page 1569

Aug 8, 2023

Future Shock Documentary

Posted by in categories: education, futurism

‘Future Shock’ is a documentary film based on the book written.
in 1970 by sociologist and futurist Alvin Toffler. Released in 1972.
with a cigar-chomping Orson Welles as on-screen narrator, this piece of futurism is darkly dystopian and oozing techno-paranoia.

Cleaned up and ‘HD formatted’ version of Zeroheadroom’s posting. https://www.youtube.com/watch?v=vVJrJk3q3MA

Aug 8, 2023

Loss of Y Chromosome and Bladder Cancer in Men

Posted by in category: biotech/medical

In men, loss of the Y chromosome in bladder cancer cells helped tumors evade the immune system and grow unchecked, a new study shows.

Aug 8, 2023

Human BioMolecular Atlas Program

Posted by in category: biotech/medical

Inaugurated in 2018, the Human BioMolecular Atlas Program (HuBMAP) endeavours to construct comprehensive spatial maps that feature a range of biomolecules such as RNA, proteins, and metabolites in human organs at single-cell resolution. This collection features the research, datasets, methods and tools generated by this project, accompanied by a Perspective, a News and Views, and links to other resources.

Aug 8, 2023

Role of M2 macrophage-derived exosomes in controlling neutrophil-mediated tissue injury in sepsis

Posted by in category: biotech/medical

In a recent study published in the Journal of Biomedical Science, researchers investigate whether M2 macrophage-derived exosomes (M2-Exos) could prevent inflammation-associated damage during sepsis-associated acute lung injury (ALI) by modulating abnormal polymorphonuclear neutrophil (PMN) behaviors.

Study: Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis. Image Credit: Kateryna Kon / Shutterstock.com.

Aug 8, 2023

Chandrayaan-3: Historic India Moon mission sends new photos of lunar surface

Posted by in category: space

If Chandrayaan-3 succeeds, India will be the first country to land near the Moon’s little-explored south pole.

Aug 8, 2023

AI.com Now Belongs to Elon Musk

Posted by in categories: Elon Musk, robotics/AI

The URL previously belonged to OpenAI, but, somehow, it’s now a landing page for Musk’s AI venture.

Aug 7, 2023

Traditional Industries In An AI World

Posted by in categories: employment, robotics/AI

Jeff Tao is the founder, CEO and core developer of TDengine.

The emergence of ChatGPT in the public eye has brought new life to the field of artificial intelligence (AI). As AI technology enters all industries, it becomes a part of our work and lives, ushering in a new industrial revolution. While jobs will be lost, new opportunities will be created for those who work with AI.

Traditional industries, such as energy and manufacturing, are even more anxious about the AI-oriented future than those in the IT sector. They want to know how they can use AI technologies to reduce costs and increase efficiency in their industries.

Aug 7, 2023

New Insights Into The Anti-Aging Properties Of Klotho

Posted by in categories: biotech/medical, life extension, neuroscience

The Klotho gene has gained increasing attention for its anti-aging properties. In the most recent installment of this series, we explored the promising cognitive benefits of administering Klotho to both mice and monkeys, the results from which may be mirrored in humans. The benefits of this circulating hormone, however, extend beyond the brain.

Klotho was first discovered as the antiaging gene in 1997 when researchers found that enhancing its expression could increase the lifespan of mice by more than 30%. Although a variety of different genes and environmental factors can influence longevity, studies have shown that Klotho-deficient mice not only have shorter lifespans but also experience more age-related complications. Premature aging in these mice often was accompanied by loss of muscle and fat tissue, thinning skin, reduced fertility, cardiovascular complications, movement abnormalities, and bone disease. Since Klotho is primarily produced in the kidneys, it is not surprising that many of these age-related complications often result from kidney dysfunction.

The kidneys generate two types of Klotho: a transmembrane protein that inserts itself into the cell membrane and mediates kidney function, and a secreted hormone that is released into the bloodstream. Individuals with naturally high levels of the hormone in their blood seem to not only live longer and be more resistant to age-related complications but also perform better on learning and memory tasks. In fact, even when a relatively small dose of Klotho is administered, animal studies have shown that the brain undergoes significant changes that allow more connections to be made in the hippocampus, the brain’s learning and memory center.

Aug 7, 2023

Don’t quit your day job: Generative AI and the end of programming

Posted by in categories: futurism, robotics/AI

Head over to our on-demand library to view sessions from VB Transform 2023. Register Here

There’s a lot of angst about software developers “losing their jobs” to AI, being replaced by a more intelligent version of ChatGPT, GitHub’s Copilot, Google’s foundation model Codey, or something similar.

AI startup founder Matt Welsh has been talking and writing about the end of programming. He’s asking whether large language models (LLMs) eliminate programming as we know it, and he’s excited that the answer is “yes”: Eventually, if not in the immediate future.

Aug 7, 2023

Inner-Ear Bone Loss Finding Opens Door to Potential New Therapies

Posted by in category: biotech/medical

The researchers were successful in showing the relationship between activin A and bone erosion in cholesteatoma. “Our study showed that targeting activin A is a potential treatment in the management of cholesteatomas,” says senior author Masaru Ishii, MD, PhD, professor.

Currently in clinical settings, the only effective treatment for cholesteatomas is complete surgical removal. However, the discovery of how a cholesteatoma can cause bone erosion in this study offers new hope for developing novel medical treatments as first-line management for cholesteatomas.

“A cholesteatoma can still return or happen again even after its surgical removal, so it is important to know what is actually causing it,” notes lead author Kotaro Shimizu.